- 61st listing on Euronext in 2025
- The company raised €13.3 million
- Market capitalisation at IPO is €38.1 million
Euronext today congratulates Più Medical on its listing on Euronext Growth Milan.
The listing of Più Medical represents Euronext’s 61st listing this year. In the placement phase, Più Medical raised €13.3 million (including €1.6 million from the potential exercise of the greenshoe option).
The free float at the time of admission is 18.11% (22.44% million assuming full exercise of the greenshoe option) and the market capitalisation at IPO amounts to €38.1 million.
Stefano Maroni, CEO of Più Medical, said: “Our listing on Euronext Growth Milan marks a key milestone for Più Medical and for the implementation of our industrial vision. We are creating places where health is not only dispensed, but managed, monitored and continuously improved through technology and proximity. Più Medical is not a pharmacy chain, but an integrated platform for health, prevention and longevity, placing people at the heart of a new approach to care.”
Fabrizio Maroni, Executive Chairman, Stefano Maroni, CEO e Fabio Giordano, CFO
About Più Medical
Più Medical is a company committed to developing a new pharmacy model based on the integration of health, prevention, and wellbeing. Through an industrial project that combines technological innovation, local presence, and a people-centred approach, Più Medical aims to redefine the role of the Italian pharmacy, transforming it into a modern, accessible ecosystem focused on community wellbeing. The goal is to build a scalable, sustainable model with a high social impact.
